BR9911440A - Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa - Google Patents
Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausaInfo
- Publication number
- BR9911440A BR9911440A BR9911440-2A BR9911440A BR9911440A BR 9911440 A BR9911440 A BR 9911440A BR 9911440 A BR9911440 A BR 9911440A BR 9911440 A BR9911440 A BR 9911440A
- Authority
- BR
- Brazil
- Prior art keywords
- osteoporosis
- prevention
- composition
- treatment
- changes due
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçãO PARA A PREVENçãO E/OU TRATAMENTO DE OSTEOPOROSE E ALTERAçõES DEVIDO à SìNDROME DE MENOPAUSA"<D>. Uma composição que pode tomar a forma de um suplemento dietético ou de um remédio real é divulgada, a qual compreende, como ingredientes característicos, propionil L-carnitina e a isoflavona genisteína para a prevenção e/ou tratamento terapêutico de osteoporose e síndrome de menopausa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98RM000417A IT1299191B1 (it) | 1998-06-23 | 1998-06-23 | Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa |
PCT/IT1999/000174 WO1999066913A2 (en) | 1998-06-23 | 1999-06-17 | Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9911440A true BR9911440A (pt) | 2001-03-20 |
Family
ID=11406005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9911440-2A BR9911440A (pt) | 1998-06-23 | 1999-06-17 | Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa |
Country Status (27)
Country | Link |
---|---|
US (1) | US6335038B1 (pt) |
EP (1) | EP1089742B1 (pt) |
JP (1) | JP4430233B2 (pt) |
KR (1) | KR20010071541A (pt) |
CN (1) | CN1306434A (pt) |
AR (1) | AR018924A1 (pt) |
AT (1) | ATE228367T1 (pt) |
AU (1) | AU755272B2 (pt) |
BR (1) | BR9911440A (pt) |
CA (1) | CA2334875C (pt) |
DE (1) | DE69904172T2 (pt) |
DK (1) | DK1089742T3 (pt) |
EE (1) | EE200000741A (pt) |
ES (1) | ES2188177T3 (pt) |
HU (1) | HU224957B1 (pt) |
IL (1) | IL140163A0 (pt) |
IS (1) | IS5764A (pt) |
IT (1) | IT1299191B1 (pt) |
MA (1) | MA26655A1 (pt) |
NO (1) | NO20006431L (pt) |
NZ (1) | NZ508877A (pt) |
PL (1) | PL192118B1 (pt) |
PT (1) | PT1089742E (pt) |
SK (1) | SK19292000A3 (pt) |
TN (1) | TNSN99132A1 (pt) |
TR (1) | TR200003735T2 (pt) |
WO (1) | WO1999066913A2 (pt) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1302863B1 (it) * | 1998-11-13 | 2000-10-10 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un |
US6476010B2 (en) | 2000-03-10 | 2002-11-05 | Hill's Pet Nutrition | Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
US20010039296A1 (en) * | 2000-03-23 | 2001-11-08 | Debasis Bagchi | Method and composition for preventing or reducing the symptoms of menopause |
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US8669282B2 (en) | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
IT1317079B1 (it) | 2000-12-21 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi. |
EP1372412A2 (en) * | 2001-03-09 | 2004-01-02 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
ES2289097T3 (es) * | 2001-03-15 | 2008-02-01 | Dsm Ip Assets B.V. | Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados. |
AUPR957001A0 (en) * | 2001-12-19 | 2002-01-24 | Novogen Research Pty Ltd | Isoflavone conjugates, derivatives thereof and therapeutic methods involving same |
WO2003068218A1 (en) * | 2002-02-15 | 2003-08-21 | N.V. Nutricia | Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
KR100542478B1 (ko) * | 2002-08-28 | 2006-01-11 | 한경대학교 산학협력단 | 석류 유래 피토에스트로겐을 함유하는 건강기능식품 |
CN1681484B (zh) * | 2002-09-09 | 2012-06-06 | 雀巢技术公司 | 用于改善皮肤质量的口服施用组合物 |
KR100520408B1 (ko) * | 2003-03-25 | 2005-10-10 | 주식회사 태평양 | 비만개선용 조성물 |
US7582674B2 (en) * | 2003-05-27 | 2009-09-01 | Dsm Ip Assets B.V. | Nutraceutical compositions and use thereof |
JP2005187454A (ja) * | 2003-12-05 | 2005-07-14 | Sankyo Co Ltd | ビタミンe含有ldl低下剤及び/又は動脈硬化抑制剤組成物 |
CN1917779B (zh) * | 2004-01-28 | 2010-06-16 | 雀巢技术公司 | 用于改善皮肤状况和防止皮肤病的营养组合物 |
KR100739280B1 (ko) | 2004-02-03 | 2007-07-12 | 가부시끼가이샤 고또스기 | 운남 홍두삼 유래 이소탁시레시놀을 성분으로 하는골다공증 치료ㆍ예방약 |
US8193240B2 (en) * | 2004-03-17 | 2012-06-05 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
CN100351248C (zh) * | 2004-07-05 | 2007-11-28 | 南京大学 | 染料木素衍生物及其制法和用途 |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
DE102004060314A1 (de) * | 2004-12-08 | 2006-08-31 | Beiersdorf Ag | Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen |
WO2006071919A2 (en) | 2004-12-29 | 2006-07-06 | Hill's Pet Nutrition, Inc. | Methods for inhibiting a decline in learning and/or memory in animals |
BRPI0519851A2 (pt) * | 2005-01-10 | 2017-05-30 | Hormos Medical Ltd | uso de uma lignana para a manufatura de uma composição para prevenir ou aliviar os sintomas relacionados à deficiência de estrogênio |
US8349317B2 (en) * | 2005-07-08 | 2013-01-08 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Use of L-carnitine or an alkanoyl L-carnitine, for the preparation of a dietary supplement or medicament for the treatment of corneal disease |
CN101262780B (zh) | 2005-07-14 | 2013-04-24 | 希尔氏宠物营养品公司 | 一种延长动物生命的方法 |
CN1939534B (zh) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
CN101365431A (zh) * | 2005-10-14 | 2009-02-11 | 帝斯曼知识产权资产管理有限公司 | 包含白藜芦醇的营养药物组合物的新颖用途 |
BRPI0618222A2 (pt) | 2005-11-02 | 2011-08-23 | Nestec Sa | composições de isoflavona para reduzir o acúmulo de gordura corporal em animais machos, e métodos para seu uso |
JP5227195B2 (ja) | 2006-02-28 | 2013-07-03 | ネステク ソシエテ アノニム | 骨成長の誘発及び骨損失の抑制のための組成物及び方法 |
WO2007099432A2 (en) | 2006-02-28 | 2007-09-07 | Council Of Scientific And Industrial Research | Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof |
EP2004169B1 (en) * | 2006-04-12 | 2012-08-08 | Unilever PLC | Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin |
US20090286872A1 (en) * | 2006-04-12 | 2009-11-19 | John Casey | Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties |
EP2004160B1 (en) * | 2006-04-12 | 2012-09-19 | Unilever PLC | Oral composition with an antiageing effect on the skin |
US8680140B2 (en) * | 2006-08-02 | 2014-03-25 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms |
US20080108696A1 (en) * | 2006-08-02 | 2008-05-08 | Brinton Roberta D | Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases |
WO2008100560A2 (en) * | 2007-02-14 | 2008-08-21 | University Of Southern California | Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
EP2343292B1 (en) | 2008-09-10 | 2014-08-06 | Asahi Glass Company, Limited | Novel prostaglandin i2 derivative |
US20110091435A1 (en) * | 2008-10-24 | 2011-04-21 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of hair loss |
CN102209535B (zh) * | 2008-11-11 | 2013-03-27 | 希格马托制药工业公司 | 用于治疗橘皮组织的化合物 |
KR101158856B1 (ko) | 2009-05-12 | 2012-06-25 | 한국생명공학연구원 | 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물 |
AU2011225259B2 (en) * | 2010-03-08 | 2015-07-23 | AGC Inc. | Novel EP4 agonist |
SG10201503032UA (en) * | 2010-06-16 | 2015-06-29 | Sigma Tau Ind Farmaceuti | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
WO2012011572A1 (ja) * | 2010-07-23 | 2012-01-26 | 国立大学法人大阪大学 | 拡張不全型心不全治療薬 |
IT201700116392A1 (it) * | 2018-04-03 | 2019-10-03 | Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1275434B (it) * | 1995-05-19 | 1997-08-07 | Farmila Farma Milano | Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante |
IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
US5702752A (en) * | 1996-03-13 | 1997-12-30 | Archer Daniels Midland Company | Production of isoflavone enriched fractions from soy protein extracts |
US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
AU6141498A (en) * | 1997-02-04 | 1998-08-25 | John V. Kosbab | Compositions and methods for prevention and treatment of vascular degenerative diseases |
-
1998
- 1998-06-23 IT IT98RM000417A patent/IT1299191B1/it active IP Right Grant
-
1999
- 1999-06-17 CN CN99807767A patent/CN1306434A/zh active Pending
- 1999-06-17 IL IL14016399A patent/IL140163A0/xx unknown
- 1999-06-17 KR KR1020007014485A patent/KR20010071541A/ko not_active Application Discontinuation
- 1999-06-17 AT AT99926749T patent/ATE228367T1/de active
- 1999-06-17 EE EEP200000741A patent/EE200000741A/xx unknown
- 1999-06-17 WO PCT/IT1999/000174 patent/WO1999066913A2/en not_active Application Discontinuation
- 1999-06-17 DK DK99926749T patent/DK1089742T3/da active
- 1999-06-17 PT PT99926749T patent/PT1089742E/pt unknown
- 1999-06-17 MA MA25636A patent/MA26655A1/fr unknown
- 1999-06-17 BR BR9911440-2A patent/BR9911440A/pt not_active IP Right Cessation
- 1999-06-17 NZ NZ508877A patent/NZ508877A/xx not_active Application Discontinuation
- 1999-06-17 SK SK1929-2000A patent/SK19292000A3/sk unknown
- 1999-06-17 ES ES99926749T patent/ES2188177T3/es not_active Expired - Lifetime
- 1999-06-17 TR TR2000/03735T patent/TR200003735T2/xx unknown
- 1999-06-17 CA CA002334875A patent/CA2334875C/en not_active Expired - Fee Related
- 1999-06-17 EP EP99926749A patent/EP1089742B1/en not_active Expired - Lifetime
- 1999-06-17 DE DE69904172T patent/DE69904172T2/de not_active Expired - Lifetime
- 1999-06-17 AU AU43909/99A patent/AU755272B2/en not_active Ceased
- 1999-06-17 HU HU0102879A patent/HU224957B1/hu not_active IP Right Cessation
- 1999-06-17 US US09/720,237 patent/US6335038B1/en not_active Expired - Lifetime
- 1999-06-17 PL PL345030A patent/PL192118B1/pl unknown
- 1999-06-17 JP JP2000555599A patent/JP4430233B2/ja not_active Expired - Fee Related
- 1999-06-23 TN TNTNSN99132A patent/TNSN99132A1/fr unknown
- 1999-06-23 AR ARP990103006A patent/AR018924A1/es unknown
-
2000
- 2000-12-08 IS IS5764A patent/IS5764A/is unknown
- 2000-12-15 NO NO20006431A patent/NO20006431L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911440A (pt) | Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa | |
BR9913288A (pt) | Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico | |
BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
BR0013122A (pt) | Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina | |
BR0115411A (pt) | Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares | |
EA200500250A1 (ru) | Аналоги тиомолибдата и их применение | |
BRPI0407950A (pt) | processo para a preparação de uma composição de higiene pessoal | |
BR0112799A (pt) | Composição farmacêutica, processo para preparação e utilização da mesma, conjunto e processo para tratamento de obesidade, utilização de um inibidor de lìpase e de um sequestrante de ácido de bìlis e processo de tratamento ou prevencão de efeitos colaterais gastrointestinais | |
BR9915334A (pt) | Mistura de aromas para mascarar o sabor desagradável de composto de zinco | |
ECSP067043A (es) | Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis | |
BR9915918A (pt) | Combinação de carnitinas e resveratrol para prevenção ou tratamento de distúrbios cerebrais ou de envelhecimento | |
NO20035473D0 (no) | Oralt administrerte doseringsformer av GABA-analogprodrugs som har reduserttoksisitet | |
BR0008687A (pt) | Métodos para o tratamento de, e para prevenir ou controlar, distúrbios gastrointestinais, disfunção da motilidade gastrointestinal, emese, e doença de refluxo gastro-esofageano em um paciente, e, composição farmacêutica | |
BR0006045A (pt) | Composição que compreende uma carnitina e glutationa, útil para aumentar a absorção de glutationa e para sinergizar seus efeitos | |
ECSP034518A (es) | Nuevos retinoides para el tratamiento de enfisema | |
BR9814885A (pt) | Combinação de um inibidor da enzima de conversão da angiotensina e de um diurético para o tratamento das desordens microcirculatórias | |
BR9912703A (pt) | Composição antioxidante, antiprolìfera, compreendendo uma carnitina e um carotenóide | |
BRPI0411665A (pt) | uso de agomelatina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica ou kit, e, métodos para o tratamento de doenças ou distúrbios responsivos a um inibidor da recaptação de serotonina e para aumentar e/ou proporcionar inìcio mais rápido do efeito terapêutico de um inibidor da recaptação de serotonina | |
BR9813996A (pt) | 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio | |
BR0209863A (pt) | Composição catártica | |
BRPI0414299A (pt) | composições farmacêuticas de liberação modificada de modafinil | |
BRPI0418854A (pt) | composições herbáceas | |
DE69917005D1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
BR9812780A (pt) | 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio | |
BR0012058A (pt) | Combinação sinérgica: gabapentina e pregabalina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4,5,6,7 E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |